Shanghai Hengrui Pharmaceutical Co., Ltd.;Jiangsu Hengrui Medicine Co., Ltd.
发明人:
Jiahua Jiang,Cheng Liao,Lianshan Zhang,Piaoyang Sun,Lin Shen,Jing Gao,Jifang Gong
申请号：
US16545004
公开号：
US20200061049A1
申请日:
2019.08.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method for preventing or treating tumor diseases with a combination of a tyrosine kinase inhibitor and a CDK4/6 inhibitor is provided. In particular, a method for preventing or treating tumor diseases, including administering to a patient a tyrosine kinase inhibitor of a compound of formula (I), or a complex, a pharmaceutically acceptable salt or a stereoisomer thereof and a CDK4/6 inhibitor is provided.
